Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,069 public trials 1,836 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Active, Not Recruiting

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

NCT04198766

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +56 more
Locations
  • City of Hope Duarte, California, United States
  • Los Angeles Cancer Network Glendale, California, United States
  • California Research Institute Los Angeles, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
View all 42 locations
View Trial Details
Active, Not Recruiting

An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib

NCT02955940

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +25 more
Locations
  • UCLA Healthcare Hematology-Oncology Santa Monica, California, United States
  • University of Louisville Louisville, Kentucky, United States
  • New York Oncology Hematology Pc. Clifton Park, New York, United States
  • Tennessee Oncology Nashville, Tennessee, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive

NCT05879822

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +36 more
Locations
  • Fundacao Pio Xii Hospital de Cancer de Barretos Barretos, Brazil
  • Cionc-Centro Integrado de Oncologia de Curitiba Curitiba, Brazil
  • Hospital Erasto Gaertner - Liga Paranaense de Combate Ao Câncer Curitiba, Brazil
  • Oncosite - Centro de Pesquisa Clinica E Oncologia Ijuí, Brazil
View all 54 locations
View Trial Details
Active, Not Recruiting

Acupuncture for Enhancing Immunotherapy in Advanced NSCLC：a Pilot Study

NCT06461338

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • The First Affiliated Hospital of Guangzhou University of Chinese Medicine. Guangzhou, Guangdong, China
  • Guangdong Provincial Hospital of Chinese Medicine Guangzhou, Guangdong, China
  • Jiangsu Provincial Hospital of Chinese Medicine Nanjing, Jiangsu, China
View Trial Details
Active, Not Recruiting

Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab

NCT06211036

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +9 more
Locations
  • Infirmary Cancer Center Mobile, Alabama, United States
  • University of Southern California Los Angeles, California, United States
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • University Cancer and Blood Center LLC Athens, Georgia, United States
View all 219 locations
View Trial Details
Active, Not Recruiting

Lorlatinib Continuation Study

NCT05144997

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • The First affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Beijing Chest Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
View all 27 locations
View Trial Details

Related conditions